PMID- 8457843 OWN - NLM STAT- MEDLINE DCOM- 19930426 LR - 20190614 IS - 0006-8993 (Print) IS - 0006-8993 (Linking) VI - 604 IP - 1-2 DP - 1993 Feb 26 TI - Cortical refractoriness to N-methyl-D,L-aspartic acid (NMA) stimulation in the lactating rat: recovery after pup removal and blockade of progesterone receptors. PG - 16-23 AB - We have previously reported that lactating rats, unlike cycling rats, are refractory to N-methyl-D,L-aspartic acid (NMA), but not kainate, in terms of behavioral responses and activation of cFos expression in the neocortex and hippocampus. To study the factors involved in the suppression of cortical activation in lactating rats in response to NMA, we examined the effects of removing either the suckling stimulus and/or progesterone. The degree of cFos expression was used as a marker for cortical activation. Whereas control suckled animals exhibited little or no cFos activation in the piriform cortex in response to NMA, cycling rats showed a high degree of activation. Blockade of the effects of progesterone or removal of the pups for 24 h, resulted in a moderate level of cFos intensity in response to NMA. Total recovery was observed only in animals who had their pups removed for 24 h and the effects of progesterone were blocked. In general, similar results were obtained in the hippocampus except that the total recovery of hippocampal activation took longer than the cortex. Thus, the deficits in cortical activation depend on the presence of both the suckling stimulus and progesterone. However, progesterone alone cannot induce these cortical deficits since pregnant rats showed no deficits in cortical activation in response to NMA when compared to cycling rats. Therefore, the suckling stimulus is required for the inhibition of NMDA-receptor mediated activation of the cortex and hippocampus. The effects of progesterone appear to act synergistically with the effects of suckling. FAU - Abbud, R AU - Abbud R AD - Department of Physiology, University of Pittsburgh, School of Medicine 15261. FAU - Hoffman, G E AU - Hoffman GE FAU - Smith, M S AU - Smith MS LA - eng GR - HD 14643/HD/NICHD NIH HHS/United States GR - NS 28730/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. PL - Netherlands TA - Brain Res JT - Brain research JID - 0045503 RN - 0 (Proto-Oncogene Proteins c-fos) RN - 0 (Receptors, Progesterone) RN - 320T6RNW1F (Mifepristone) RN - 4G7DS2Q64Y (Progesterone) RN - 6384-92-5 (N-Methylaspartate) SB - IM GS - cFos MH - Animals MH - Cerebral Cortex/drug effects/*physiology MH - Female MH - Genes, fos/*drug effects MH - Hippocampus/drug effects/*physiology MH - Immunohistochemistry MH - *Lactation MH - Mifepristone/pharmacology MH - N-Methylaspartate/*pharmacology MH - Ovariectomy MH - Progesterone/*physiology MH - Proto-Oncogene Proteins c-fos/analysis MH - Rats MH - Rats, Sprague-Dawley MH - Receptors, Progesterone/drug effects/*physiology EDAT- 1993/02/26 00:00 MHDA- 1993/02/26 00:01 CRDT- 1993/02/26 00:00 PHST- 1993/02/26 00:00 [pubmed] PHST- 1993/02/26 00:01 [medline] PHST- 1993/02/26 00:00 [entrez] AID - 0006-8993(93)90347-P [pii] AID - 10.1016/0006-8993(93)90347-p [doi] PST - ppublish SO - Brain Res. 1993 Feb 26;604(1-2):16-23. doi: 10.1016/0006-8993(93)90347-p.